This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
Tidewater (TDW)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
TDWPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will JPMorgan-Coinbase Tie-Up Bring Crypto Closer to Mainstream?
by Swayta Shah
JPM partners with COIN to enable direct crypto access, stablecoin rewards and tokenized banking. This marks a major step toward mainstream adoption of crypto.
BACNegative Net Change JPMNegative Net Change PNCNegative Net Change COINNegative Net Change
cryptocurrency fin-tech finance
Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks
by Rimmi Singhi
Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.
BPositive Net Change PAGPNegative Net Change STNEPositive Net Change PHINPositive Net Change ASTHNegative Net Change
auto-tires-trucks fin-tech gold medical oil-energy
3 "Cheap" Tech Stocks to Buy Now: HPE, STNE, UDMY
by Shaun Pruitt
Making their way onto the coveted Zacks Rank #1 (Strong Buy) list, several tech stocks are emerging as standouts in terms of their affordability and valuation.
HPEPositive Net Change STNEPositive Net Change UDMYNegative Net Change MSFTNegative Net Change NVDANegative Net Change
artificial-intelligence computers dividends e-commerce fin-tech investing software tech-stocks value-stocks
Chime Financial to Post Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
CHYM eyes second-quarter revenue growth on its payment-driven model, though EPS expectations indicate a decline.
MRXNegative Net Change STEPNegative Net Change CHYMNegative Net Change
earnings fin-tech finance
Pagaya Q2 Earnings on the Cards: A Smart Buy or Risky Bet?
by Nikita Kataruka
PGY expects strong Q2 results, with revenues anticipated to rise 29% year over year.
TREEPositive Net Change LCNegative Net Change PGYPositive Net Change
earnings-preview fin-tech finance
Central Garden (CENT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CENTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
The Zacks Analyst Blog Highlights PayPal, Visa and Mastercard
by Zacks Equity Research
PayPal tumbles post-earnings despite raised guidance, but fundamentals, innovation, and valuation suggest upside ahead.
MANegative Net Change VNegative Net Change PYPLNegative Net Change
fin-tech
The Zacks Analyst Blog Highlights Interactive Brokers, Visa, Robinhood Markets and PayPal Holdings
by Zacks Equity Research
Interactive Brokers, Visa, Robinhood, and PayPal gain spotlight as crypto exposure and earnings momentum draw investor interest.
VNegative Net Change IBKRNegative Net Change PYPLNegative Net Change HOODNegative Net Change
fin-tech
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IVZPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?
by Moumita C. Chattopadhyay
PayPal stock plunges 10% despite strong Q2 results and raised guidance, highlighting tension between progress and expectations.
PYPLNegative Net Change MANegative Net Change VNegative Net Change
artificial-intelligence fin-tech
Should You Buy Medpace (MEDP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
MEDPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Robinhood's Q2 Earnings Beat on Trading Surge & Higher NIR
by Zacks Equity Research
HOOD's Q2 earnings crush estimates as surging trading activity and higher net interest revenues fuel strong growth.
SCHWNegative Net Change IBKRNegative Net Change HOODNegative Net Change
earnings fin-tech finance
UBS Group Q2 Earnings & Revenues Rise Y/Y, Expenses Decline
by Zacks Equity Research
UBS posted a $2.39B Q2 profit, boosted by Wealth and Investment Bank gains, while costs fell and Credit Suisse integration advanced.
DBNegative Net Change UBSNegative Net Change IBNNegative Net Change
earnings fin-tech
PGY's Asset-Light Balance Sheet Model: Does it Offer a Safe Bet?
by Nikita Kataruka
Pagaya's asset-light model shields it from credit risk while powering 213% YTD gains and sharp earnings growth forecasts.
TREEPositive Net Change UPSTPositive Net Change PGYPositive Net Change
fin-tech finance
Visa Q3 Earnings Beat Estimates on Strong Cross-Border Volumes
by Zacks Equity Research
V posts 23% y/y EPS growth in Q3 and beats estimates, fueled by rising cross-border and processed transaction volumes.
VNegative Net Change COHRPositive Net Change TRUPositive Net Change APGNegative Net Change
business-services earnings fin-tech finance payments
TEMENOS GROUP (TMSNY)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TMSNYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TransAlta (TAC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TACPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PRMEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Regions Financial (RF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy Visa Stock on Impressive Q2 Earnings and Strong Business Visibility
by Nalak Das
Visa posts strong Q2 earnings, expands in AI and stablecoins, and eyes long-term growth through digital payment innovation.
MANegative Net Change VNegative Net Change WUPositive Net Change PYPLNegative Net Change
fin-tech
StoneCo vs. Upstart: Which Fintech Stock Has More Upside This Year?
by Moumita C. Chattopadhyay
STNE and UPST are taking distinct fintech routes. One is scaling in Brazil, while the other is rewriting U.S. credit with AI. Which has more upside?
STNEPositive Net Change UPSTPositive Net Change
artificial-intelligence fin-tech
Should You Buy AppFolio (APPF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
APPFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
F.N.B. (FNB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FNBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines